https://www.marketscreener.com/quote/stock/COMPASS-THERAPEUTICS-INC-115071909/news/Compass-Therapeutics-Receives-FDA-Fast-Track-Designation-for-the-Investigation-of-CTX-009-in-Combina-46530752/?utm_source=telegram&utm_medium=social&utm_campaign=share